Recent Posts

News, Blog, Product
Congenica v3.0 - Overcoming Challenges to Accelerate Variant Classification
Posted 9th December 2020

Congenica v3.0 - Overcoming Challenges to Accelerate Variant Classification

Read More
Blog , Product , COVID
How to research COVID-19 host genetics?
Posted 8th December 2020

How to research COVID-19 host genetics?

Read More
News , Blog
Inclusion in AJHG “Year in Review” 2020
Posted 7th December 2020

Inclusion in AJHG “Year in Review” 2020

Read More
Patient Advocacy , Chapter 1
Charles’ Story
Posted 4th December 2020

Charles’ Story

Read More
Patient Advocacy , Chapter 8 , Chapter 7 , Chapter 1 , Chapter 2
The complexity of epilepsy - an overview
Posted 1st December 2020

The complexity of epilepsy - an overview

Read More
News , Investor
Congenica Appoints Dr. Muthu Meyyappan as Chief Commercial Officer
Posted 1st December 2020

Congenica Appoints Dr. Muthu Meyyappan as Chief Commercial Officer

Read More
News , Investor
Congenica Appoints Dr. Sam Roberts as Non-Executive Director
Posted 20th November 2020

Congenica Appoints Dr. Sam Roberts as Non-Executive Director

Read More
News
Inherited Disorders: Bioinformatic Analysis that Surpasses All Others
Posted 17th November 2020

Inherited Disorders: Bioinformatic Analysis that Surpasses All Others

Read More
News , Investor
Congenica Completes $50m Series C Funding Round to Advance Clinical Genomic Analysis Software and Data Platform
Posted 9th November 2020

Congenica Completes $50m Series C Funding Round to Advance Clinical Genomic Analysis Software and Data Platform

Read More
Blog , Investor
Our plans for the future: a video message from our CEO and Chairman
Posted 9th November 2020

Our plans for the future: a video message from our CEO and Chairman

Read More
Blog
The culture changes needed to mainstream genomics
Posted 26th October 2020

The culture changes needed to mainstream genomics

Read More
previous 1 ...
6 7 8 9 10
... 19 next
News , Blog , Product
Congenica v3.0 - Overcoming Challenges to Accelerate Variant Classification
Posted 9th December 2020

Congenica v3.0 - Overcoming Challenges to Accelerate Variant Classification

Read More
Blog , Product , COVID
How to research COVID-19 host genetics?
Posted December Dec 8th 2020

How to research COVID-19 host genetics?

Read More
News , Blog
Inclusion in AJHG “Year in Review” 2020
Posted December Dec 7th 2020

Inclusion in AJHG “Year in Review” 2020

Read More
Patient Advocacy , Chapter 1
Charles’ Story
Posted December Dec 4th 2020

Charles’ Story

Read More
Patient Advocacy , Chapter 8 , Chapter 7 , Chapter 1 , Chapter 2
The complexity of epilepsy - an overview
Posted December Dec 1st 2020

The complexity of epilepsy - an overview

Read More
News , Investor
Congenica Appoints Dr. Muthu Meyyappan as Chief Commercial Officer
Posted December Dec 1st 2020

Congenica Appoints Dr. Muthu Meyyappan as Chief Commercial Officer

Read More
News , Investor
Congenica Appoints Dr. Sam Roberts as Non-Executive Director
Posted November Nov 20th 2020

Congenica Appoints Dr. Sam Roberts as Non-Executive Director

Read More
News
Inherited Disorders: Bioinformatic Analysis that Surpasses All Others
Posted November Nov 17th 2020

Inherited Disorders: Bioinformatic Analysis that Surpasses All Others

Read More
News , Investor
Congenica Completes $50m Series C Funding Round to Advance Clinical Genomic Analysis Software and Data Platform
Posted November Nov 9th 2020

Congenica Completes $50m Series C Funding Round to Advance Clinical Genomic Analysis Software and Data Platform

Read More
Blog , Investor
Our plans for the future: a video message from our CEO and Chairman
Posted November Nov 9th 2020

Our plans for the future: a video message from our CEO and Chairman

Read More
Blog
The culture changes needed to mainstream genomics
Posted October Oct 26th 2020

The culture changes needed to mainstream genomics

Read More
previous 1 ...
6 7 8 9 10
... 19 next
CE 60px-Conformité_Européenne - WHITE27001 RGB Tick 60x60 Congenica UL® ISO 13485:2016 A28485 HIPAA Compliance

Copyright © 2021 Congenica Ltd. Company number: 8273616 Registered in England and Wales

Congenica is available as a CE Marked IVD clinical decision support platform for clinical diagnostic use for inherited genetic disorders in the UK and EU, Iceland, Lichtenstein, Norway, Switzerland and Turkey. In all other countries, ensuring compliance with relevant local, national and international clinical laboratory regulations is the responsibility of the laboratory.